IP Library › Granted Patent US 9,579,077
Granted Patent B2
US 9,579,077 · App. 12/518,695 · Granted Feb 28, 2017

Multiple imaging mode tissue marker

Inventors: R. Michael Casanova (Scottsdale, AZ); Dnyanesh A. Talpade (Kinnelon, NJ); Chandrashekhar P. Pathak (Phoenix, AZ)
Assignee: C.R. Bard, Inc.
A61B6/481A61B8/481A61B90/39A61B2090/376A61B2090/3908A61B2090/3925A61B2090/3995
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,579,077
App. No.
12/518,695
Filed
Jun 11, 2009
Granted
Feb 28, 2017
Kind
B2
Art Unit
3737
USPC
600/431
Abstract

An intracorporeal marker for marking a site within living tissue of a host having a body of porous hydroxyapatite whose physical properties permit the body to be distinguished from human soft tissue under visualization using ultrasonic and radiation imaging modalities.

Claims (13)

1. An intracorporeal marker, for marking a site within living tissue of a host, comprising:

a body comprised of first and second distinct materials, the body having a core region made of the first material completely surrounded by an outer region made of the second material, the first material being comprised of porous hydroxyapatite having physical properties that permit the body to be distinguished from human soft tissue under visualization using ultrasonic and radiation imaging modalities, the second material being comprised of a second hydroxyapatite, and wherein the porous hydroxyapatite of the core region has a first porosity and the second hydroxyapatite of the outer region has a second porosity, wherein the first porosity of the porous hydroxyapatite of the core region is higher than the second porosity of the second hydroxyapatite of the outer region.

2. The marker of claim 1 , wherein the body has a cylindrical shape.

3. The marker of claim 1 , wherein the body has gas-filled pores.

4. The marker of claim 1 , wherein the outer region has a surface that is water-impermeable.

5. An intracorporeal marker for marking a site within living tissue of a host, comprising:

a porous body having a central region and a surface that surrounds the central region, the body having pores filled with gas, the sizes of the pores and the gas being such that the body is configured to be visualized under ultrasound, wherein the porous body comprises a first dense hydroxyapatite at the central region, a second dense hydroxyapatite at the surface, and a porous hydroxyapatite between the central region and the surface, and wherein the porous hydroxyapatite has porosity levels in a range of 30 percent to 80 percent.

6. The intracorporeal marker of claim 5 , wherein the hydroxyapatite body changes in porosity from the first dense hydroxyapatite at the central region to the porous hydroxyapatite at the intermediate region and changes in porosity from the porous hydroxyapatite at the intermediate region to the second dense hydroxyapatite at the surface.

7. An intracorporeal tissue marker, comprising first and second distinct materials, the first material comprising a core of the marker and having a first density, the second material completely surrounding the first material and having a second density, the first density being lower than the second density, and wherein each of the first material and the second material comprises hydroxyapatite.

8. The intracorporeal marker of claim 7 , wherein the first material comprises a porous hydroxyapatite and the second material comprises hydroxyapatite having a density greater than the porous hydroxyapatite.

9. The intracorporeal marker of claim 7 , further comprising a third material completely surrounded by the first material, the first density being lower than the third density.

10. The intracorporeal marker of claim 9 , wherein each of the first material, the second material, and the third material comprises hydroxyapatite.

11. The intracorporeal marker of claim 9 , wherein the first material comprises porous hydroxyapatite having porosity levels in a range of 30 percent to 80 percent, and each of the second material and the third material comprises hydroxyapatite having a porosity lower than the porous hydroxyapatite.

Continuity (2)
Provisional Application 60869636 · Dec 12, 2006
Related Publication 20100030072A1 · Feb 4, 2010